DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Positive impactCompany

CORONA Remedies Limited — Press Release

NSE 3 hrs ago·22 Oct 2026, 1:09 pm

Corona Remedies

Corona Remedies Limited has announced that it has received a GMP Compliance Certification from Brazil's health regulator, ANVISA. This certification validates the company's manufacturing processes and quality standards, allowing it to export its pharmaceutical products to the Brazilian market.

This development is significant for investors as it opens a new, high-potential revenue stream for the company. Regulatory approval from a major market like Brazil is a key milestone that can boost the company's growth prospects and international footprint.

Investors should monitor the company's future financial reports to see how this new market impacts its overall sales and profitability. The successful execution of this expansion will be crucial for the stock's performance.

Affected stocks

Bullish1 stock

Corona Remedies

CORONA Bullish

₹2,043.80

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Corona Remedies (CORONA).
Category: Company.
AI reads the tone as positive (potentially bullish) for the stock.

Why it matters

A routine update for Corona Remedies. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.